Oligonucleotide Delivery Platform for Improved Nucleic Acid-based Treatments
PacDNA, a registered company, is opening the door for the use of RNA-based oligonucleotide drugs across a range of disease areas.
Published: 18th February 2022

IP Status
- Patent application submitted
- Patented
Seeking
- Development partner
- Commercial partner
- Licensing
- University spin out
- Seeking investment